“Genius” Grants Given

The MacArthur Foundation announces this year’s awardees.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Beth Stevens, Boston Children's Hospital neuroscientist, is one of this year's MacArthur Fellows.IMAGE: JOHN D. & CATHERINE T. MACARTHUR FOUNDATIONTwo dozen of the brightest minds on Earth this week recently received recent phone calls from the MacArthur Foundation that may just change their lives—or at least their next five years. These folks are the 2015 MacArthur Fellows, and they’ll be getting $625,000 over the next half-decade (a no-strings-attached stipend colloquially known as “genius grants”) to pursue their work in a range of fields, from poetry and puppetry to inorganic chemistry and neuroscience. “These 24 delightfully diverse MacArthur Fellows are shedding light and making progress on critical issues, pushing the boundaries of their fields, and improving our world in imaginative, unexpected ways,” MacArthur Foundation President Julia Stasch said in a statement. “Their work, their commitment, and their creativity inspire us all.”

Among this year’s crop of MacArthur Fellows are several scientists, including Kartik Chandranm, an environmental engineer from Columbia University; Cornell University organic chemist William Dichtel; computational biologist John Novembre of the University of Chicago; neuroscientist Beth Stevens of Boston Children's Hospital and Harvard Medical School; Lorenz Studer, a stem-cell biologist at Memorial Sloan-Kettering Cancer Center; and inorganic chemist Peidong Yang of the University of California, Berkeley.

“We try to reach people who have shown evidence of exceptional creativity but show the potential for more in the future,” Cecilia Conrad, the foundation’s managing director, told The New York Times.

“As a scientist, I tend to be drawn to areas where there’s very little known,” said Stevens, who studies how microglial cells influence brain development and neurodevelopmental ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies